The resulting study, published in the medical journal JAMA Network Open, looked at the health data of 21,790 veterans with type 2 diabetes to compare three different GLP-1 RAs - liraglutide, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback